Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemung Financial (CHMG) Common Equity: 2016-2025

Historic Common Equity for Chemung Financial (CHMG) over the last 10 years, with Sep 2025 value amounting to $245.3 million.

  • Chemung Financial's Common Equity rose 11.17% to $245.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.3 million, marking a year-over-year increase of 11.17%. This contributed to the annual value of $215.3 million for FY2024, which is 10.28% up from last year.
  • According to the latest figures from Q3 2025, Chemung Financial's Common Equity is $245.3 million, which was up 4.40% from $235.0 million recorded in Q2 2025.
  • Over the past 5 years, Chemung Financial's Common Equity peaked at $245.3 million during Q3 2025, and registered a low of $155.5 million during Q3 2022.
  • Its 3-year average for Common Equity is $205.7 million, with a median of $201.2 million in 2024.
  • Its Common Equity has fluctuated over the past 5 years, first fell by 24.56% in 2022, then rose by 29.75% in 2024.
  • Chemung Financial's Common Equity (Quarterly) stood at $211.5 million in 2021, then dropped by 21.31% to $166.4 million in 2022, then increased by 17.34% to $195.2 million in 2023, then rose by 10.28% to $215.3 million in 2024, then increased by 11.17% to $245.3 million in 2025.
  • Its Common Equity was $245.3 million in Q3 2025, compared to $235.0 million in Q2 2025 and $228.3 million in Q1 2025.